The PPARα/FGF21 axis formed by PPARα and FGF21 is widely involved in maintaining liver lipid metabolism homeostasis, and regulating the PPARα/FGF21 axis may be an important way to prevent and treat NASH. Here, FGF21 is linked to metabolic dysfunction-associated steatohepatitis.